Jesse Jones
Mark Bolding
Henrik Ullman3
Satoshi Tateshima- 1Departments of Neurosurgery and Radiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States
- 2Department of Radiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States
- 3Department of Radiology, School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
- 4Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
Brain AVMs are rare but serious vascular lesions that often pose a management dilemma between the risk of various treatment modalities and uncertain natural history during observation. We describe preliminary data on the use of focused ultrasound as a novel therapeutic strategy. In an AVM model, one session of ultrasound gradually reduced flow through the lesion without inducing rupture. Due to its non-invasive yet immediate ablative effects, focused ultrasound may allow safer treatment of AVMs. However, further studies are needed to clarify its efficacy and side effect profile.
Introduction
The current treatment of brain arteriovenous malformations (AVM) consists of surgical resection, stereotactic radiosurgery (SRS) and/or endovascular embolization. A specific set of advantages and limitations applies to each approach or combination thereof, depending on the angioarchitecture and other patient factors (1). High intensity focused ultrasound (HIFU) is emerging as an alternative treatment for several neurological disorders including brain tumor and movement disorders (2). However, the role of HIFU in brain AVM has been less well-studied.
HIFU induces tissue ablation in a rapid, non-invasive, and non-ionizing fashion that may overcome some limitations of established brain AVM treatments by transmitting sound waves through the intact cranium onto a targeted volume of interest. Surgical resection is predicated on access to the malformation, which is untenable in deeply located lesions such as the thalamus. Location is less problematic in SRS, although ionizing radiation often leads to perilesional leukoencephalopathy and radiation necrosis. The cognitive effects of radiation in pediatric patients significantly limit its utilization. Furthermore, the year's long delay from treatment to obliterative vasculopathy prolongs hemorrhage risk, which persists until complete occlusion of the shunt. Endovascular embolization rarely produces complete AVM occlusion and rather serves a more adjunctive role to surgery and/or SRS in larger or acutely ruptured lesions.
With the limitations of conventional therapies in mind, we sought to assess whether HIFU ablation is feasible in a swine model of brain AVM.
Methods
The study was approved by the local Animal Research Council (ARC) prior to study inception. The porcine AVM model was surgically created, as described previously (3), in a juvenile female Yucatan swine. Following a period of 4 weeks to allow maturation of the shunt, the animal was brought to the MRI suite and placed under general anesthesia. An endotracheal tube was inserted, and mechanical respiration initiated. Vital parameters, including basal temperature, respiratory rate, blood pressure, heart rate, and peripheral oxygen saturation, were continuously monitored. The animal was positioned prone with the HIFU transducer placed ventral to the mandibular angle.
Baseline MRI was performed, including T1W MPRAGE, FSE T2, and T1W contrast enhanced time-resolved MRA (CE-MRA), on a 3 Tesla MR scanner (Siemens Prisma, Erlangen Germany). CE-MRA was obtained after intravenous injection of 0.5 mmol gadobutrol (Bayer, Whippany NJ) diluted in normal saline with 1.18 s/frame and a total duration of 30.68 s. The rete mirabile was identified on anatomic sequences and high flow shunting confirmed by CE-MRA. An MR Thermographic sequence (single slice spoiled gradient echo) was initially performed through the rete, however, it was found to be non-diagnostic because of susceptibility artifact from the skull base. HIFU trajectory was planned through a ventral approach to the skull base where an acoustic window to the rete was identified (Figure 1). The bilateral rete was then targeted with a 1.0 MHz HIFU system with 128-element phased array transducer (model number LF-LAS-128, Image Guided Therapy, Pessac France) and sequentially ablated with interleaved CE-MRA to assess flow reduction. Treatment was concluded due to heating of intervening tissue (core temperature > 39°C). CE-MRA was repeated six times throughout the ablation session.
Figure 1. Pre (A) and post (B) ablation T2 weighted images. (B) Illustrates T2 prolongation within the bilateral rete mirabile (arrows) as well as the facial soft tissues, indicating edema. (C) T2 weighted sagittal section showing ultrasound transducer ventral approach.
Post procedure imaging was obtained with T2 and CE-MRA sequences. At the conclusion of the study, a lethal dose of anesthetic was administered intravenously per University veterinary protocol.
Results
The rete mirabile was clearly visualized on pre-procedure imaging (Figure 1). CE-MRA showed T1 shortening within the nidal-type vessels of the rete, as well as rapid transit time, consistent with high vascular flow through the AVM model (Figure 2).
Figure 2. Pre- (A) and post- (B) ablation MRA at 14 s after peripheral IV gadolinium injection. The bilateral rete mirabile (arrows) show decreased contrast enhancement.
Following sequential HIFU ablation, CE-MRA showed progressive flow reduction through the rete shunt as evidenced by increasing mean transit time and time to peak, as well as decreasing blood flow (Figure 3). The final post procedure CE-MRA showed a 27% reduction in blood flow relative to baseline values and 32% reduction compared to the maximum. The area under the curve was calculated for the CE-MRA runs, showing a significant decrease in signal intensity (Figure 3B, p < 0.01 for Spearman r). Post-ablation T2 weighted MRI and necroscopy demonstrated thermal injury to the facial soft tissues along the ultrasound trajectory.
Figure 3. (A) Time resolved MRA enhancement curve of the rete mirabile at baseline and after sequential ablation sessions. Run 1 is baseline curve before treatment. (B) decrease in MRA intensity vs. total incident energy.
Discussion
Despite advancements in the treatment of brain AVM over the past decades, many lesions still pose a challenge to safe and complete obliteration. Treatment related complications have in fact been shown to result in worse outcomes than the natural history, at least on short term follow-up (4). From this frustrating background also comes opportunity for novel approaches, such as HIFU.
In contrast to applications in functional neurosurgery and neuro-oncology (5, 6) HIFU for intracranial vascular lesions is less studied and no investigation of brain AVM has been published. However, data from peripheral vascular ablation by focused ultrasound in both animal models and man is encouraging (7–14).
To this background, we describe preliminary experience applying HIFU to a brain AVM model. The swine carotid rete is an established in vivo AVM model for SRS (15) that recapitulates the high arterial flow through a plexiform nidal structure. In the current study, we utilize this model and demonstrate its use for the development of a HIFU ablation technique. HIFU of swine AVM model is indeed feasible, as demonstrated above. Sufficient heating was achieved to markedly reduce nidus size and shunting. A workflow of sequential ablation with stepwise increasing energy, interspaced with rapid CE-MRA, allowed frequent assessment of the treatment effect.
However, several challenges were evidenced by incomplete obliteration of the nidus and thermal soft tissue injury. First, the rete mirabile is difficult to insonate due to adjacent bone and air containing structures. Unfortunately, wide-array transducers currently in use for human brain HIFU applications are not amenable to the rete trajectory. We have since developed a practice of percutaneously accessing the tympanic cavities and infusing saline to widen the acoustic window (Figure 4). Additionally, MR Thermography can be utilized to monitor heat deposition along the US trajectory in real time. An US attenuation map created by returning echoes would also be helpful in estimating energy deposition at the focal spot. Second, the significant heat sink effect mediated by blood flow convection in AVM limits energy deposition. While this was partially overcome with progressively higher power, there may be a role for adjunctive flow-control techniques such as induced hypotension, balloon occlusion of feeding pedicles, or transient asystole.
Figure 4. Percutaneous access of the external auditory canal and infusion of saline into the mastoid air cells (arrows) to widen the acoustic window. (A) pre, (B) percutaneous access, and (C) post saline infusion.
Further studies are needed to continue development of HIFU for brain AVM treatment and to assess long term effects. The current swine model will aid this development, albeit with several limitations which must be improved upon. Heat deposition by the ultrasound beam could potentially result in tissue damage along the treatment path. In addition, serious complications could result if vital blood vessels are inadvertently damaged during treatment. Unlike current neurological HIFU applications (16), this model utilizes a bone window beam trajectory through soft tissue rather than cranium, which may alter ablation characteristics. Future work on this method should emphasize more refined control of the beam shape and trajectory and improved techniques for real time monitoring temperature of the tissue along the beam path and within the AVM. In conclusion, the current study provides encouraging results on the feasibility of HIFU for brain AVM. Additional preclinical work are necessary to improve ultrasonic access to the rete mirabile, assess the long term effects of treatment, and to optimize energy deposition through flow control and real time treatment monitoring strategies.
Data Availability Statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics Statement
The animal study was reviewed and approved by UCLA Animal Research Council.
Author Contributions
JJ conceived the experiments, supervised the HIFU procedure, and edited the manuscript. MB analyzed the experimental data, created figures, and edited the manuscript. HU primarily wrote the manuscript. NK performed the rete anastomosis surgery and edited the manuscript. ST oversaw project design and implementation, assisted with grant funding, and edited the manuscript. All authors contributed to the article and approved the submitted version.
Funding
This work was funded by an internal UCLA Radiology Department exploratory grant as well as CTSI core voucher UL1TR001881.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Abbreviations
AVM, Arteriovenous malformation; CE-MRA, Contrast Enhanced Magnetic Resonance Angiography; HIFU, High Intensity Focused Ultrasound; SRS, Stereotactic Radiosurgery.
References
1. Solomon RA, Connolly ES. Arteriovenous malformations of the brain. N Engl J Med. (2017) 376:1859–66. doi: 10.1056/NEJMra1607407
2. Khanna N, Gandhi D, Steven A, Frenkel V, Melhem ER. Intracranial applications of MR imaging-guided focused ultrasound. Am J Neuroradiol. (2017) 38:426–31. doi: 10.3174/ajnr.A4902
3. Massoud TF, Ji C, Viñuela F, Guglielmi G, Robert J, Duckwiler GR, et al. An experimental arteriovenous malformation model in swine: anatomic basis and construction technique. AJNR Am J Neuroradiol. (1994) 15:1537–45.
4. Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. (2014) 383:614–21. doi: 10.1016/S0140-6736(13)62302-8
5. Coluccia D, Fandino J, Schwyzer L, O'Gorman R, Remonda L, Anin J, et al. First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound. J Ther Ultrasound. (2014) 2:17. doi: 10.1186/2050-5736-2-17
6. Fishman PS, Frenkel V. Treatment of movement disorders with focused ultrasound. J Cent Nerv Syst Dis. (2017) 9:1179573517705670. doi: 10.1177/1179573517705670
7. Hynynen K, Colucci V, Chung A, Jolesz F. Noninvasive arterial occlusion using MRI-guided focused ultrasound. Ultrasound Med Biol. (1996) 22:1071–7. doi: 10.1016/S0301-5629(96)00143-3
8. Ichihara M, Sasaki K, Umemura S, Kushima M, Okai T. Blood flow occlusion via ultrasound image-guided high-intensity focused ultrasound and its effect on tissue perfusion. Ultrasound Med Biol. (2007) 33:452–9. doi: 10.1016/j.ultrasmedbio.2006.08.016
9. Shaw CJ, Civale J, Botting KJ, Niu Y, Ter Haar G, Rivens I, et al. Noninvasive high-intensity focused ultrasound treatment of twin-twin transfusion syndrome: a preliminary in vivo study. Sci Transl Med. (2016) 8:347ra95. doi: 10.1126/scitranslmed.aaf2135
10. van Breugel JM, Nijenhuis RJ, Ries MG, Toorop RJ, Vonken EJ, Wijlemans JW, et al. Non-invasive magnetic resonance-guided high intensity focused ultrasound ablation of a vascular malformation in the lower extremity: a case report. J Ther Ultrasound. (2015) 3:23. doi: 10.1186/s40349-015-0042-7
11. Ghanouni P, Kishore S, Lungren MP, Bitton R, Chan L, Avedian R, et al. Treatment of low-flow vascular malformations of the extremities using MR-guided high intensity focused ultrasound: preliminary experience. J Vasc Interv Radiol. (2017) 28:1739–44. doi: 10.1016/j.jvir.2017.06.002
12. Okai T, Ichizuka K, Hasegawa J, Matsuoka R, Nakamura M, Shimodaira K, et al. First successful case of non-invasive in-utero treatment of twin reversed arterial perfusion sequence by high-intensity focused ultrasound. Ultrasound Obstet. Gynecol. (2013) 42:112–4. doi: 10.1002/uog.12466
13. Yan X, Zhao C, Tian C, Wen S, He X, Zhou Y. Ultrasound-guided high-intensity focused ultrasound ablation for treating uterine arteriovenous malformation. BJOG. (2017) 124(Suppl 3):93–6. doi: 10.1111/1471-0528.14749
14. Liu JL, Lin XL, Zhou H, Pan JH, Liu GH, Shuai HL, et al. Ultrasound-guided high-intensity focused ultrasound as pretreatment before surgical excision for fertility-preserving management of uterine arteriovenous malformation. Eur J Obstet Gynecol. Reprod Biol. (2019) 240:384–6. doi: 10.1016/j.ejogrb.2019.07.030
15. Jahan R, Solberg TD, Lee D, Medin P, Tateshima S, De Salles A, et al. An arteriovenous malformation model for stereotactic radiosurgery research. Neurosurgery. (2007) 61:152–9; discussion 9. doi: 10.1227/01.neu.0000279736.07683.1e
Keywords: arteriovenous malformation, embolization, high intensity focus ultrasound, non-invasive ablation, MRI guided ablation
Citation: Jones J, Bolding M, Ullman H, Kaneko N and Tateshima S (2021) Focused Ultrasound Ablation of an Arteriovenous Malformation Model. Front. Neurol. 12:671380. doi: 10.3389/fneur.2021.671380
Received: 23 February 2021; Accepted: 12 May 2021;
Published: 03 June 2021.
Edited by:
Dileep Yavagal, University of Miami, United StatesReviewed by:
Nabeel A. Herial, Thomas Jefferson University, United StatesPriyank Khandelwal, Rutgers University, Newark, United States
Copyright © 2021 Jones, Bolding, Ullman, Kaneko and Tateshima. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jesse Jones, jgjones@uab.edu